Learning From HIV: Pharmacology's Role In The Management Of Hepatitis C
Charles Flexner, MD
Professor of Medicine, Pharmacology and Molecular Sciences, and International Health
Johns Hopkins University, Baltimore, Maryland
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc. Copyright © 2011. All rights reserved.
At the completion of this educational session, participants should be able to:
- Know the clinical importance of pharmacologic factors in the management and control of HCV infection with and without HIV-coinfection.
- Understand possible approaches to managing clinically significant drug-drug interactions involving new directly-acting agents (DAA) for HCV.
- Discuss similarities and differences in the pharmacologic management of hepatitis virus infections
Charles W. Flexner is Professor of Medicine in the Divisions of Clinical Pharmacology and Infectious Diseases, and Professor of Pharmacology and Molecular Sciences in the Johns Hopkins University School of Medicine. He is also Professor of International Health in the Johns Hopkins University Bloomberg School of Public Health. Dr. Flexner is an acknowledged expert on the basic and clinical pharmacology of drugs for HIV/AIDS and related infections, including viral hepatitis and tuberculosis. His scientific contributions include work on the important roles of pharmacokinetic enhancement, adherence, and dosing frequency in the long-term management of HIV/AIDS. He has also published extensively on anti-infective drug transport and metabolism, and metabolic drug interactions. Dr. Flexner is the Principal Investigator of the Johns Hopkins University AIDS Clinical Trials Unit (ACTU) supported by the NIH, and is Chair of the AIDS Clinical Trials Group (ACTG) Translational Research and Drug Development (TRADD) Committee.
To obtain CME credit for this and other PRN programs, please visit the PRN Video Channel at the Clinical Education Initiative (CEI) web site http://www.ceitraining.org/prn-video/. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.